Published in FEMS Microbiol Lett on June 15, 1998
Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature (1985) 4.60
Role of chromosomal rearrangement in N. gonorrhoeae pilus phase variation. Cell (1985) 3.30
Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun (2001) 2.67
Antigenic variation of gonococcal pilus involves assembly of separated silent gene segments. Proc Natl Acad Sci U S A (1986) 2.53
Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique. J Clin Microbiol (1979) 2.13
Medical psychological observations during the Holocaust: escape into health. Adv Mind Body Med (1999) 2.02
In vitro binding of Candida albicans yeast cells to human fibronectin. Can J Microbiol (1984) 1.98
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun (2000) 1.93
Stroke volume variation as a predictor of fluid responsiveness in patients undergoing brain surgery. Anesth Analg (2001) 1.75
Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma (2001) 1.63
Developmental regulation of the cysteine-rich outer-membrane proteins of murine Chlamydia trachomatis. J Gen Microbiol (1988) 1.52
Biotyping of Candida albicans: results of an international collaborative survey. J Clin Microbiol (1989) 1.50
Evaluation of a new system for the rapid identification of clinically important yeasts. J Clin Microbiol (1976) 1.42
In vitro adherence of Candida albicans to human corneocytes. Inhibition by chitin-soluble extract. Acta Derm Venereol (1988) 1.40
Elevated plasma atrial natriuretic peptide levels after occlusion of the thoracic aorta. Chest (1999) 1.37
Pathogenesis of vaginal candidiasis: studies with a mutant which has reduced ability to adhere in vitro. J Med Vet Mycol (1986) 1.23
The effect of tidal volume and intravascular volume state on systolic pressure variation in ventilated dogs. Intensive Care Med (1989) 1.20
Adherence of Candida albicans to human vaginal epithelial cells: inhibition by amino sugars. Exp Cell Biol (1982) 1.19
Pathology of Shy-Drager syndrome. J Neuropathol Exp Neurol (1979) 1.16
In vitro and in vivo adherence of Candida albicans to mucosal surfaces. Ann Microbiol (Paris) (1984) 1.14
Positive end-expiratory pressure-induced hemodynamic changes are reflected in the arterial pressure waveform. Crit Care Med (1996) 1.09
Correlative relationship between adherence of Candida albicans to human vaginal epithelial cells in vitro and candidal vaginitis. Sabouraudia (1984) 1.09
Evaluation of simplified Frykman and AO classifications of fractures of the distal radius. Assessment of interobserver and intraobserver agreement. Int Orthop (1998) 1.09
Role of ligand exchange processes in the reaction kinetics of the antitumor drug cis-diamminedichloroplatinum(II) with its targets. Cancer Res (1985) 1.06
Penicillinase plasmid-linked genetic determinants for enterotoxins B and C1 production in Staphylococcus aureus. Infect Immun (1985) 1.04
Interaction of Candida albicans with genital mucosal surfaces: involvement of fibronectin in adherence. J Infect Dis (1988) 1.03
Effect of Candida albicans cell wall components on the adhesion of the fungus to human and murine vaginal mucosa. Mycopathologia (1988) 1.01
Detection of specific Bacillus anthracis spore biomarkers by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom (2001) 0.97
Attachment of Candida to mammalian tissues--clinical and experimental studies. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.93
Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen. Infect Immun (2005) 0.93
Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment. Leuk Lymphoma (2000) 0.92
Dynamic properties of a diluted pyrochlore cooperative paramagnet (Tb(p)Y(1-p))2Ti2O7. Phys Rev Lett (2004) 0.92
Adhesion of Candida albicans to mouse intestinal mucosa in vitro: development of the assay and test of inhibitors. J Med Vet Mycol (1986) 0.92
The use of systolic pressure variation in hemodynamic monitoring during deliberate hypotension in spine surgery. J Clin Anesth (1990) 0.91
Application of transcranial doppler ultrasonography for the diagnosis of brain death. Intensive Care Med (1999) 0.90
Adherence of Candida albicans to buccal and vaginal epithelial cells: ultrastructural observations. Can J Microbiol (1984) 0.90
Isolation of the Candida albicans histidinol dehydrogenase (HIS4) gene and characterization of a histidine auxotroph. J Bacteriol (1990) 0.90
Editorial. J Exp Anal Behav (1982) 0.88
The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures. J Antimicrob Chemother (1997) 0.88
Isolation of a petite mutant from a histidine auxotroph of Candida albicans and its characterization. Mycopathologia (1998) 0.88
Respiratory failure and intensive care treatment in bone marrow-transplanted patients. Intensive Care Med (1996) 0.88
Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components. Vaccine (2005) 0.87
Genetic relatedness of Candida albicans to asporogenous and ascosporogenous yeasts as reflected by nucleic acid homologies. Microbios (1974) 0.87
New strategies in vaccination against fungal infections. J Med Vet Mycol (1994) 0.86
Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever. Isr Med Assoc J (2000) 0.86
Stress, immunity and mycotic diseases. J Med Vet Mycol (1994) 0.86
Chronic massive knee effusion in familial Mediterranean fever. Semin Arthritis Rheum (1997) 0.85
Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis. Clin Exp Immunol (2007) 0.85
Adhesion of Candida albicans to epithelial cells effect of polyoxin D. Mycopathologia (1991) 0.85
Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals. Sabouraudia (1981) 0.84
Susceptibility of Prototheca species to antifungal agents. Antimicrob Agents Chemother (1976) 0.84
Gonococcal pilus: genetics and structure. Curr Top Microbiol Immunol (1985) 0.84
Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up. Pediatr Pulmonol (1998) 0.83
Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B. J Antimicrob Chemother (2008) 0.83
Isolation of Candida tropicalis from an orbital infection as a complication of maxillar osteomyelitis. Infection (1974) 0.83
Relationship between cellular diadenosine 5',5'''-P1,P4-tetraphosphate level, cell density, cell growth stimulation and toxic stresses. Exp Cell Res (1986) 0.83
Epithelial keratitis due to rhodotorula. Ophthalmologica (1973) 0.83
Systolic pressure variation--a way to recognize dynamic hyperinflation. Br J Anaesth (1996) 0.83
Interferon and natural killer cell activity in patients with exanthem subitum. Pediatr Infect Dis J (1992) 0.82
Cellular actin is affected by interaction with Candida albicans. FEMS Microbiol Lett (2000) 0.82
Systemic candidiasis in mice immunized with Candida albicans ribosomes. Mycopathologia (1985) 0.82
[Surgery for thoraco-abdominal aortic aneurysm]. Harefuah (1991) 0.82
Interaction of Candida albicans with murine gastrointestinal mucosa: effect of irradiation on adherence in vitro. J Med Vet Mycol (1989) 0.82
Suppressive action of Candida albicans on the immune response in mice. Exp Cell Biol (1979) 0.81
Immunogenicity in calves of a crude ribosomal fraction of Trichophyton verrucosum: a field trial. Vaccine (1995) 0.81
Immune responses elicited by vaccinations with Candida albicans ribosomes in cyclophosphamide treated animals. Mycopathologia (1985) 0.81
Survival after left ventricular rupture following blunt chest injury. Am J Emerg Med (1996) 0.81
Natural premedication for mast cell proliferative disorders. J Ethnopharmacol (1995) 0.81
Pressure versus volume-controlled ventilation with a laryngeal mask airway in paediatric patients. Paediatr Anaesth (2001) 0.81
Outcome of patients with scleroderma admitted to intensive care unit. A report of nine cases. Clin Exp Rheumatol (2006) 0.80
Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections. Chemotherapy (1975) 0.80
Differentiation of 23-S ribosomal RNA cistrons from 16-S ribosomal RNA cistrons in Escherichia coli by the sequence complementarity test. Biochim Biophys Acta (1973) 0.80
Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions. Infect Immun (1981) 0.80
Spectrum of CFTR mutations in Argentine cystic fibrosis patients. Clin Genet (1997) 0.80
Antibody formation in experimental immunizations with Candida albicans ribosomal fractions. Mycopathologia (1978) 0.80
Natural pathogens of laboratory animals and their effects on research. Med Mycol (2000) 0.79
Complete screening of the CFTR gene in Argentine cystic fibrosis patients. Clin Genet (2002) 0.79
Effect of implantable cardioverter-defibrillator shocks on QT dispersion. Am J Cardiol (2000) 0.79
Antigenic relationships between Candida albicans and various yeasts as reflected by immunoglobulin-class specificity. Pathol Microbiol (Basel) (1975) 0.79
Effect of Candida albicans metabolite(s) on cellular actin. FEMS Microbiol Lett (2002) 0.79
Protection against systemic infections with various Candida species elicited by vaccination with Candida albicans ribosomes. Sabouraudia (1985) 0.78
Sclerotherapy of esophageal varices--Argentinian experience. Endoscopy (1983) 0.78
Adhesion and interaction of Candida albicans with mammalian tissues in vitro and in vivo. Methods Enzymol (1995) 0.78
Vaccines against fungal infections. Crit Rev Microbiol (1987) 0.78
The pharmacokinetics of morphine and lidocaine in critically ill patients. Intensive Care Med (1999) 0.78
Interaction of Candida albicans with murine gastrointestinal mucosa from methotrexate and 5-fluorouracil treated animals: in vitro adhesion and prevention. J Med Vet Mycol (1990) 0.78
Bedside laparoscopy in the ICU: report of four cases. J Laparoendosc Adv Surg Tech A (2001) 0.78
Rhodotorula rubra--cause of eye infection. Mykosen (1975) 0.78
Serum anti-candida albicans antibodies in candidal and non-candidal vaginitis. Zentralbl Bakteriol Orig A (1977) 0.78
Pharmacokinetics of amphotericin B in serum and tissues in mice treated with amphotericin B-Intralipid. Med Mycol (2003) 0.78
Fatal systemic candidiasis of gastrointestinal origin: an experimental model in mice compromised by anti-cancer treatment. J Med Vet Mycol (1992) 0.78
Yeasts in banal external ocular inflammations. Ophthalmologica (1975) 0.78
Cytokines in mice treated with amphotericin B-intralipid. Med Mycol (2004) 0.78